Review Indicates No Causal Association Exists Between Aluminum-Adjuvanted Vaccines And Serious Or Long-Term Health Outcomes

HealthDay (5/7, Gotkine) reports a systematic review of 59 studies found that “no causal association appears to exist between aluminum-adjuvanted vaccines and serious or long-term health outcomes.” Across the studies, the researchers “consistently found no association between aluminum-adjuvanted vaccines and serious or long-term health outcomes, including asthma, autism spectrum disorder, or other chronic conditions, based on high-quality evidence from randomized controlled trials and large cohorts.” In addition, “high-certainty randomized controlled trials revealed no consistent increase in risk with aluminum-adjuvanted formulations for common adverse events such as headache and myalgia. When observed, differences were small and mainly mild to moderate in severity.” The authors concluded, “These findings are consistent with the broader postlicensure safety evidence base, which supports continued use of aluminum-adjuvanted vaccines in immunization programs.” The review was published in The BMJ.